2013 ACCF/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Acute Coronary Syndromes and Coronary Artery Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards)

2013 ACCF/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Acute Coronary Syndromes and Coronary Artery Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards)
复制标题

DOI:
10.1016/j.jacc.2012.10.005
复制
发表时间:
2013-03-05
影响因子:
24
通讯作者:
Turner, Melanie
Turner, Melanie
中科院分区:
医学1区
文献类型:
--
作者:
Cannon, Christopher P.;Brindis, Ralph G.;Turner, Melanie

文献摘要

被引文献

相似文献

在心脏病学领域,大规模临床试验和登记研究为数十万患者的治疗和结局提供了丰富的数据。这些努力中的许多都集中在患有急性冠状动脉综合征(ACS)的患者,其范围从ST段抬高心肌梗死(STEMI)到非ST段抬高心肌梗死(NSTEMI)到不稳定型心绞痛(UA)。这些数据已被用于评估这些患者的药物和介入治疗的有效性,定义新的治疗方法,并通过评估ACS患者的治疗过程和质量以及结局来指导临床治疗。
In the field of cardiology, large-scale clinical trials and registries have provided a wealth of data on the treatment and outcomes for hundreds of thousands of patients. Many of these efforts have focused on patients with acute coronary syndromes (ACS), which range from ST-segment elevation myocardial infarction (STEMI) to non–ST-segment elevation myocardial infarction (NSTEMI) to unstable angina (UA). These data have been used to evaluate the effectiveness of the pharmacological and interventional management of these patients, define new therapies, and guide clinical care through evaluation of both the process and the quality of care and outcomes for patients with ACS.